WHO WE ARE
We are committed to staying at the forefront of the regulatory and pharmacovigilance field, continuously implementing the latest industry advancements to deliver the highest standard of service. RegBridge specializes in offering comprehensive regulatory and pharmacovigilance services to pharmaceutical companies operating in the CIS, EAEU, Turkey, UK, EU, and Balkan countries. Our goal is to be the trusted partner in your journey towards regulatory success. With over a decade of experience, our highly qualified team is dedicated to assisting you in achieving your business objectives.
With a comprehensive suite of services tailored to the unique regulatory and pharmacovigilance landscape of each country, we empower companies to navigate complex processes with confidence and efficiency, enabling them to successfully launch their products in the region.
Operating under a one-window governance model, RegBridge ensures streamlined project management while retaining the flexibility to customize services, meeting each client's unique needs. We are a client-focused company, guided by our core values of quality, compliance, and timely delivery with a high sense of accountability and integrity.
Mission
Is to provide expert guidance and tailored solutions in regulatory and pharmacovigilance services that streamline the approval process and facilitate market access, ensuring rapid, consistent and sustained access of patients to essential medicine, while prioritizing patient safety and supporting their safe and effective use throughout the product lifecycle.OUR VISION
Is to be the preferred partner globally, through excellence in regulatory, pharmacovigilance and customer service. With a dedicated team of experts we aspire to set gold standards for the industry.REGULATORY AFFAIRS
Regulatory services across the region covering the full scope of services from dossier development to full lifecycle management. Read morePHARMACOVIGILANCE
Comprehensive local and regional pharmacovigilance services, including QPPV and LPPV support, with dedicated safety management throughout the pre- and post-authorization stages of the product lifecycle. Read more
We are proud to announce that RegBridge has achieved ISO 9001:2015 certification in the field of Regulatory Affairs services through an audit conducted by UKAS-accredited certification body, Intertek.
ISO 9001 standard is an internationally recognized standard, ensuring that our Quality Management System (QMS) meets the highest global benchmarks for quality management and customer satisfaction. It reflects our commitment to delivering excellence and adhering to best practices worldwide by continuous improvement in business operations.
This milestone is a result of our robust internal processes, commitment to innovation, and unwavering focus on quality. It empowers us to refine our operations and maintain the highest standards across processes and teamwork.
We believe that achieving ISO 9001:2015 certification strengthens RegBridge’s market position as a dynamic and fast-growing service provider. This accomplishment underscores our unwavering commitment to our core values: Guaranteeing Compliance, Ensuring Quality, Respecting Timelines, Delivering Client Satisfaction, Fostering Integrity, and Empowering Accountability, which guide every aspect of our operations and services.
RegBridge is pleased to announce the establishment of its new office in Tallinn, Estonia - marking a significant step in the company’s strategic growth and commitment to strengthening its presence across Europe.
This expansion reinforces RegBridge’s mission to drive regulatory excellence and streamline market access for life-saving medicines within the EU. Estonia’s advanced digital infrastructure, transparent regulatory environment, and growing pharmaceutical ecosystem make it an ideal hub for delivering high-quality regulatory affairs, pharmacovigilance, and compliance solutions.
“Establishing a presence in Tallinn is a strategic milestone and reflects our dedication to serving clients across Europe with even greater accessibility and efficiency.” said Nargiz Asgarova, Founder and CEO of RegBridge. “We are eager to cultivate new partnerships within the Baltic region and remain committed to delivering the high-touch, expert-driven solutions to our clients worldwide to help them navigate complex regulatory landscapes.”
RegBridge is pleased to announce the strategic expansion of its regulatory and pharmacovigilance service offerings to Türkiye. This launch marks a significant milestone in the company’s global commitment to supporting pharmaceutical and biotech clients in high-growth, strategically vital markets.
Türkiye is recognized as a regional powerhouse with a dynamic regulatory landscape and a rapidly developing pharmaceutical sector. By extending its services to this market, RegBridge aims to provide crucial local expertise, enabling clients to navigate the country’s compliance requirements and bring essential products to market efficiently and in full regulatory alignment.
“Our vision is to become the preferred global partner by setting gold standards in regulatory affairs, pharmacovigilance, and customer service,” said Nargiz Asgarova, CEO of RegBridge. “With a dedicated team of experts, we aim to bring that excellence to every region we serve - now including Türkiye.”
RegBridge is pleased to announce the strategic expansion of its regulatory and pharmacovigilance services into the United Kingdom and the European Union.
Originally established as a regional consultancy specialized in the CIS and EAEU, with further development in Türkiye, RegBridge has evolved into a global partner operating across borders. This milestone reinforces our mission to connect pharmaceutical companies with both emerging and established markets, ensuring safe, compliant, and timely patient access worldwide.
As an ISO-certified organization, this growth reflects our commitment to quality, compliance, and integrity. We extend our gratitude to our dedicated team and partners for their role in our continuous advancement and for upholding the highest standards of excellence in every territory we serve.
RegBridge is officially extending its regulatory and pharmacovigilance operations into the Balkan region — a territory rapidly emerging as a strategic gateway for the life sciences industry.
With many Balkan nations modernizing their healthcare infrastructure and streamlining regulatory frameworks to align with international standards, the region offers significant untapped potential for pharmaceutical growth and clinical development.
Our expansion ensures that RegBridge partners have the on-the-ground intelligence needed to navigate these diverse local requirements. We are committed to simplifying market entry across Southeast Europe, providing the regulatory bridge that transforms regional complexity into seamless operational success.
